BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25880480)

  • 1. ESI-MS/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts.
    Wildburger NC; Wood PL; Gumin J; Lichti CF; Emmett MR; Lang FF; Nilsson CL
    J Proteome Res; 2015 Jun; 14(6):2511-9. PubMed ID: 25880480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell Xenografts.
    Wildburger NC; Zhou S; Zacharias LG; Kroes RA; Moskal JR; Schmidt M; Mirzaei P; Gumin J; Lang FF; Mechref Y; Nilsson CL
    J Proteome Res; 2015 Sep; 14(9):3932-9. PubMed ID: 26185906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells.
    Shinojima N; Hossain A; Takezaki T; Fueyo J; Gumin J; Gao F; Nwajei F; Marini FC; Andreeff M; Kuratsu J; Lang FF
    Cancer Res; 2013 Apr; 73(7):2333-44. PubMed ID: 23365134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.
    Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; Coccè V; Bonomi A; Buccarelli M; Pascucci L; Alessandri G; Pessina A; Ricci-Vitiani L; Falchetti ML; Pallini R
    Stem Cell Res Ther; 2017 Mar; 8(1):53. PubMed ID: 28279193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
    Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
    Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface analysis of lipids by mass spectrometry: more than just imaging.
    Ellis SR; Brown SH; In Het Panhuis M; Blanksby SJ; Mitchell TW
    Prog Lipid Res; 2013 Oct; 52(4):329-53. PubMed ID: 23623802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.
    Hata N; Shinojima N; Gumin J; Yong R; Marini F; Andreeff M; Lang FF
    Neurosurgery; 2010 Jan; 66(1):144-56; discussion 156-7. PubMed ID: 20023545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.
    Giladi ND; Ziv-Av A; Lee HK; Finniss S; Cazacu S; Xiang C; Waldman Ben-Asher H; deCarvalho A; Mikkelsen T; Poisson L; Brodie C
    Oncotarget; 2015 Sep; 6(26):22680-97. PubMed ID: 26267319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ionizing radiation augments glioma tropism of mesenchymal stem cells.
    Thomas JG; Parker Kerrigan BC; Hossain A; Gumin J; Shinojima N; Nwajei F; Ezhilarasan R; Love P; Sulman EP; Lang FF
    J Neurosurg; 2018 Jan; 128(1):287-295. PubMed ID: 28362237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous detection of phosphatidylcholines and glycerolipids using matrix-enhanced surface-assisted laser desorption/ionization-mass spectrometry with sputter-deposited platinum film.
    Ozawa T; Osaka I; Ihozaki T; Hamada S; Kuroda Y; Murakami T; Miyazato A; Kawasaki H; Arakawa R
    J Mass Spectrom; 2015 Nov; 50(11):1264-9. PubMed ID: 26505771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
    Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS
    J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
    Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
    Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.
    Shimizu Y; Gumin J; Gao F; Hossain A; Shpall EJ; Kondo A; Parker Kerrigan BC; Yang J; Ledbetter D; Fueyo J; Gomez-Manzano C; Lang FF
    J Neurosurg; 2022 Mar; 136(3):757-767. PubMed ID: 34450587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas.
    Oliva CR; Markert T; Gillespie GY; Griguer CE
    Oncotarget; 2015 Feb; 6(6):4330-44. PubMed ID: 25726526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Folate Metabolism Is Selectively Cytotoxic to Glioma Stem Cells and Effectively Cooperates with Differentiation Therapy to Eliminate Tumor-Initiating Cells in Glioma Xenografts.
    Okada M; Suzuki S; Togashi K; Sugai A; Yamamoto M; Kitanaka C
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma.
    Egea V; von Baumgarten L; Schichor C; Berninger B; Popp T; Neth P; Goldbrunner R; Kienast Y; Winkler F; Jochum M; Ries C
    Cell Death Differ; 2011 May; 18(5):853-63. PubMed ID: 21127499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the lipidome of xenografts using MALDI-IMS and UHPLC-ESI-QTOF.
    Fernández R; Lage S; Abad-García B; Barceló-Coblijn G; Terés S; López DH; Guardiola-Serrano F; Martín ML; Escribá PV; Fernández JA
    J Am Soc Mass Spectrom; 2014 Jul; 25(7):1237-46. PubMed ID: 24760294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
    Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
    Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
    Cheng P; Wang J; Waghmare I; Sartini S; Coviello V; Zhang Z; Kim SH; Mohyeldin A; Pavlyukov MS; Minata M; Valentim CL; Chhipa RR; Bhat KP; Dasgupta B; La Motta C; Kango-Singh M; Nakano I
    Cancer Res; 2016 Dec; 76(24):7219-7230. PubMed ID: 27569208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.